Prophylactic implantable cardioverter defibrillator therapy did not reduce mortality in patients with a prior myocardial ...

One of the timeliest and, some say controversial, topics in clinical cardiac electrophysiology today is the proper role of the implantable cardioverter-defibrillator (ICD) in the treatment of ...

(HealthDay News) — There is a lower risk of one-year ventricular arrhythmias or death in women with nonischemic cardiomyopathy and an implantable cardioverter defibrillator (ICD) compared with men, ...

More than 25% of ICD patients experienced complications during a mean follow-up of almost 4 years, although serious complications such as intraoperative death or ICD system infections are rare.

Abbott announced that a cardiac resynchronization therapy defibrillator and an implantable cardioverter defibrillator to treat patients with potentially life-threatening heart rhythms and ...

The REFINE-ICD results highlight the need to find better ways to identify at-risk patients who might benefit, one expert says ...

A standard test of the implantable cardioverter defibrillator (ICD) is linked to significant thought-processing problems that improve for most patients within a year after the device is inserted ...

A wearable automatic defibrillator may be an alternative to an implantable cardiac defibrillator for a small group of patients, say researchers. There are few large, randomized and controlled ...

Summary GlobalData's Medical Devices sector report, "Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2017" provides an overview of Implantable Cardioverter ...

Implantable cardioverter defibrillator (ICD) therapy is used in patients with severe left ventricular systolic dysfunction.  The REFINE-ICD trial investigated whether an ICD could improve survival in ...